Indeed, Cxcr2 antagonism attenuated lung angiogenesis and fibrosis in mice challenged with bleomycin [245], supporting that Cxcl2 is an important angiogenic factor that may regulate pulmonary fibrosis development in mice. Here, CXCR2 is linked to pulmonary fibrosis.